Company intelligence / Profile preview

Corey Hua Biotechnology

Manhattan, Kansas, United States

Ownership: Private
Development stage: Other

Overview

Corey Hua Biotechnology is a research-driven biotechnology company focused on the discovery and development of novel lead compounds for major diseases, including Alzheimer's disease, breast cancer, and viral infections. The company leverages advanced organic synthesis methodologies and collaborative research between chemists, biologists, and medical scientists to create innovative therapeutic solutions. Its primary focus lies in the design and evaluation of bioactive small molecules and biosensors. Corey Hua Biotechnology aims to translate academic breakthroughs into clinical applications to address significant unmet medical needs.

Therapeutic areas: Infectious DiseasesNeurologyOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Kansas State University

Beyond the preview

Go deeper on Corey Hua Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corey Hua Biotechnology.

Explore the full profile